Cargando…

Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach

Malignant Pleural Mesothelioma (MPM) is a rare and aggressive neoplasm of the pleural mesothelium, mainly associated with asbestos exposure and still lacking effective therapies. Modern targeted biological strategies that have revolutionized the therapy of other solid tumors have not had success so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lisini, Daniela, Lettieri, Sara, Nava, Sara, Accordino, Giulia, Frigerio, Simona, Bortolotto, Chandra, Lancia, Andrea, Filippi, Andrea Riccardo, Agustoni, Francesco, Pandolfi, Laura, Piloni, Davide, Comoli, Patrizia, Corsico, Angelo Guido, Stella, Giulia Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396500/ https://www.ncbi.nlm.nih.gov/pubmed/34445720 http://dx.doi.org/10.3390/ijms22169014

Ejemplares similares

The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma
por: Lettieri, Sara, et al.
Publicado: (2021)

Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study
por: Saracino, Laura, et al.
Publicado: (2021)

Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?
por: Lettieri, Sara, et al.
Publicado: (2021)

Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge
por: Abbott, David Michael, et al.
Publicado: (2020)

From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary Perspective
por: Accordino, Giulia, et al.
Publicado: (2020)

Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer
por: Stella, Giulia Maria, et al.
Publicado: (2023)

The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review
por: Stella, Giulia Maria, et al.
Publicado: (2022)

Managing Malignant Pleural Mesothelioma in the Age of Personalized Medicine: Where Are We and What Is Still Missing?
por: Stella, Giulia Maria, et al.
Publicado: (2022)

COVID-19 epidemic in a Respiratory Diseases Unit: predictor ranking and mining
por: Stella, Giulia M., et al.
Publicado: (2021)

Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience
por: Falanga, Francesco, et al.
Publicado: (2022)

Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and grow
por: Kovacs, Ildiko, et al.
Publicado: (2022)

Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma
por: De Fonseka, Duneesha, et al.
Publicado: (2022)

Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
por: Nava, Sara, et al.
Publicado: (2021)

The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints
por: Stella, Giulia M., et al.
Publicado: (2023)

Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
por: Røe, Oluf Dimitri, et al.
Publicado: (2015)

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma
por: Pignochino, Ymera, et al.
Publicado: (2015)

New Updates of the Imaging Role in Diagnosis, Staging, and Response Treatment of Malignant Pleural Mesothelioma
por: Romei, Chiara, et al.
Publicado: (2021)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020)

Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study
por: Cova, Emanuela, et al.
Publicado: (2019)

Computed Tomography and Spirometry Can Predict Unresectability in Malignant Pleural Mesothelioma
por: Bellini, Alice, et al.
Publicado: (2021)

Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
por: Morani, Federica, et al.
Publicado: (2021)

Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review
por: Stella, Giulia Maria, et al.
Publicado: (2022)

Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency
por: Barzon, Valentina, et al.
Publicado: (2022)

Immunotherapy in malignant pleural mesothelioma: a review of literature data
por: Menis, Jessica, et al.
Publicado: (2021)

Metabolic rewiring and redox alterations in malignant pleural mesothelioma
por: Urso, Loredana, et al.
Publicado: (2019)

Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells
por: Coccè, Valentina, et al.
Publicado: (2021)

Second Surgery for Recurrent Malignant Pleural Mesothelioma after Multimodality Treatment: A Systematic Review
por: Bellini, Alice, et al.
Publicado: (2022)

Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma
por: Pinton, Giulia, et al.
Publicado: (2017)

Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma
por: Al Khatib, MHD Ouis, et al.
Publicado: (2023)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Relapse Patterns and Tailored Treatment Strategies for Malignant Pleural Mesothelioma Recurrence after Multimodality Therapy
por: Bellini, Alice, et al.
Publicado: (2021)

Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy
por: Grosso, Federica, et al.
Publicado: (2018)

Diagnostic imaging and workup of malignant pleural mesothelioma
por: Cardinale, Luciano, et al.
Publicado: (2017)

Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia
por: Zonca, Sara, et al.
Publicado: (2017)

Sarcopenia as a Predictor of Short- and Long-Term Outcomes in Patients Surgically Treated for Malignant Pleural Mesothelioma
por: Faccioli, Eleonora, et al.
Publicado: (2022)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells
por: Pinton, Giulia, et al.
Publicado: (2016)

Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
por: Cavallari, Ilaria, et al.
Publicado: (2019)

CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned
por: Stella, Giulia Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3qjitjbj4shogm23aj5jdk3fca